|
|
Volumn 352, Issue 10, 2005, Pages 1036-1038
|
|
Chemotherapy for brain tumors - A new beginning
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NITROSOUREA DERIVATIVE;
TEMOZOLOMIDE;
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
DACARBAZINE;
DRUG DERIVATIVE;
METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;
BRAIN TUMOR;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
EDITORIAL;
GENE MUTATION;
GLIOBLASTOMA;
HUMAN;
MEDICAL DECISION MAKING;
MEDULLOBLASTOMA;
META ANALYSIS;
PRIORITY JOURNAL;
PROMOTER REGION;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
SURVIVAL RATE;
SYSTEMATIC REVIEW;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADJUVANT CHEMOTHERAPY;
ADULT;
CEREBELLUM TUMOR;
GENE SILENCING;
GENETICS;
NOTE;
PRESCHOOL CHILD;
SURVIVAL;
ADULT;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRAIN NEOPLASMS;
CEREBELLAR NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CHILD, PRESCHOOL;
DACARBAZINE;
GENE SILENCING;
GLIOBLASTOMA;
HUMANS;
MEDULLOBLASTOMA;
O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;
SURVIVAL ANALYSIS;
|
|
EID: 14744270886
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMe058010 Document Type: Editorial |
|
Times cited : (77)
|
|
References (8)
|
